NRCS
NOTICE OF REGISTRATION CONFIRMATION EMAILED
25/05/2022
Voltar para busca
Dado oficial do USPTO
SKIN GENES RX
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
SKIN GENES RX
ST13
US500000088129177Classe
3, 5, 42, 44
Pedido
88129177
Registro
6741385
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
84
Atualização mais recente
25/05/2022
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
3, 5, 42, 44
Data de depósito
24/09/2018
Data de registro
24/05/2022
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
24/05/2022
Última transação
24/05/2022
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Supplemental Register
Fundamento do pedido
Intent to use, Foreign priority
Primeiro uso
24/10/2020
Primeiro uso no comércio
24/10/2020
Código do desenho
4
Tipo de titular
01
Localização do titular
Toronto, Ontario, CA
Examinador
GILLES, DEBORAH
Unidade examinadora
M10
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
D. C. (pessoa física)
Representantes
Maria v. Hardison Tassan & Hardison
Classificação técnica
Classes Nice
Classe 3Classe 5Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 3
(Based on 44(e)) Cosmetic skin care preparations
Classe 5
(Based on 44(e)) Medicated skin care preparations
Classe 42
(Based on Use in Commerce) Providing scientific analysis based upon results of testing in the field of genetics and skin phenotyping for the purposes of recommending treatment options for skin conditions
Classe 44
(Based on Use in Commerce) Cosmetic consultation services relating to skin care; medical consultation services relating to skin care
Publicações
Histórico de despachos e eventos da marca no USPTO.
84 publicações encontradas
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
24/05/2022
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
21/04/2022
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
18/04/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
06/04/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/04/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
06/04/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/04/2022
AAUA
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
01/04/2022
IUAA
USE AMENDMENT ACCEPTED
31/03/2022
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
04/03/2022
IUAF
USE AMENDMENT FILED
04/03/2022
EAAU
TEAS AMENDMENT OF USE RECEIVED
03/03/2022
RDX3
NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED
27/02/2022
RDX1
ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED
27/02/2022
RRDX
ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED
27/02/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/02/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/02/2022
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
02/02/2022
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
28/01/2022
GNFR
FINAL REFUSAL E-MAILED
28/01/2022
CNFR
FINAL REFUSAL WRITTEN
28/01/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
30/12/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
30/12/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
29/11/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
29/11/2021
NREV
NOTICE OF REVIVAL - E-MAILED
19/11/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
19/11/2021
PETG
PETITION TO REVIVE-GRANTED
19/11/2021
PROA
TEAS PETITION TO REVIVE RECEIVED
19/11/2021
MAB2
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
27/09/2021
ABN2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
25/09/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
14/03/2021
GNRT
NON-FINAL ACTION E-MAILED
14/03/2021
CNRT
NON-FINAL ACTION WRITTEN
14/03/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
20/02/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
20/02/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
29/01/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
29/01/2021
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
27/01/2021
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
13/08/2020
GNSL
LETTER OF SUSPENSION E-MAILED
13/08/2020
CNSL
SUSPENSION LETTER WRITTEN
13/08/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/08/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/08/2020
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
31/07/2020
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
08/07/2020
GNSI
INQUIRY TO SUSPENSION E-MAILED
08/07/2020
CNSI
SUSPENSION INQUIRY WRITTEN
08/07/2020
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
07/01/2020
GNSL
LETTER OF SUSPENSION E-MAILED
07/01/2020
CNSL
SUSPENSION LETTER WRITTEN
07/01/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
17/12/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
17/12/2019
ALIE
ASSIGNED TO LIE
17/12/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/12/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
31/07/2019
GNRT
NON-FINAL ACTION E-MAILED
31/07/2019
CNRT
NON-FINAL ACTION WRITTEN
31/07/2019
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
01/07/2019
GNSL
LETTER OF SUSPENSION E-MAILED
01/07/2019
CNSL
SUSPENSION LETTER WRITTEN
01/07/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
01/07/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
01/07/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
01/07/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/07/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/07/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/07/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/06/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/06/2019
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
07/06/2019
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
25/05/2019
GNSL
LETTER OF SUSPENSION E-MAILED
25/05/2019
CNSL
SUSPENSION LETTER WRITTEN
25/05/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
20/05/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
20/05/2019
ALIE
ASSIGNED TO LIE
19/05/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/05/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
15/11/2018
GNRT
NON-FINAL ACTION E-MAILED
15/11/2018
CNRT
NON-FINAL ACTION WRITTEN
15/11/2018
DOCK
ASSIGNED TO EXAMINER
07/11/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
29/09/2018
NWAP
NEW APPLICATION ENTERED
27/09/2018
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace SKIN GENES RX ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.